FASST study of lanifibranor in diffuse cutaneous systemic sclerosis does not meet primary endpoint Feb. 19, 2019
Saniona reports data from second part of phase IIa study of Tesomet in Prader-Willi syndrome Feb. 19, 2019
RSS